EP3542792
25-Hýdroxývítamín D með stýrða losun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.4.2008EP published:
28.6.2023EP application number:
19172946.6
EP translation filed:
28.8.2023Grant published:
15.9.2023EPO information:
European Patent Register
Max expiry date:
24.4.2028Expiry date:
24.4.2027Next due date:
30.4.2027
Title in English:
CONTROLLED RELEASE 25-HYDROXYVITAMIN DLanguage of the patent:
English
Timeline
Today
25.4.2008EP application
28.6.2023EP Publication
28.8.2023Translation submitted
15.9.2023Registration published
24.4.2027Expires
Owner
Name:
EirGen Pharma Ltd.Address:
Westside Business Park Old Kilmeaden Road, Waterford X91 YV67, IE
Name:
Opko Renal, LLCAddress:
4400 Biscayne Boulevard, Miami, FL 33137, US
Inventor
Name:
Bishop, Charles W.Address:
Miami, FL 33130, US
Name:
Tabash, Samir P.Address:
Whitby, Ontario L1R 2Z9, CA
Name:
Agudoawu, Sammy A.Address:
Mississauga, Ontario L5M 0C5, CA
Name:
White, Jay A.Address:
Newmarket, Ontario L3X 1T3, CA
Name:
Crawford, Keith H.Address:
Parker, CO 80138, US
Name:
Messner, Eric J.Address:
Lake Forest, IL Illinois 60045, US
Name:
Petkovich, P. MartinAddress:
Kingston, Ontario K7M 4E8, CA
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
91385307 PDate:
25.4.2007Country:
US
Classification
Categories:
A61K 9/48, A61K 31/593, A61K 47/06, A61K 47/14, A61K 47/44
Annual fees
Number
Paid
Expires
Payer
Number: 17
Paid: 2.4.2024
Expires: 24.4.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 16.4.2025
Expires: 24.4.2026
Payer: Árnason Faktor ehf.
Number: 19
Paid: 28.4.2026
Expires: 24.4.2027
Payer: Árnason Faktor ehf.